Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

P M Guy1, J V Platko, L C Cantley

  • 1Department of Pharmacology, Cornell University, Ithaca, NY 14853.

Proceedings of the National Academy of Sciences of the United States of America
|August 16, 1994
PubMed
Summary

p180erbB3, a receptor tyrosine kinase, shows significantly impaired protein tyrosine kinase activity compared to the EGF receptor. This suggests a defect in its intrinsic kinase function, despite proper receptor expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meaningful change: Defining the interpretability of changes in endpoints derived from interactive and mHealth technologies in healthcare and clinical research.

Journal of rehabilitation and assistive technologies engineering·2020
Same author

Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.

Oncogene·2017
Same author

Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.

Oncogene·2017
Same author

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Predicting Suicidal Behavior In Veterans And Active Military Personnel: Possibilities For Electronic Deployment To Discover A Predictive Assessment.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

[56] Carbodiimide modification of proteins.

Methods in enzymology·2012

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Protein kinases possess conserved residues crucial for catalytic activity.
  • The p180erbB3 receptor tyrosine kinase has altered residues in its catalytic domain, suggesting impaired function.
  • Epidermal Growth Factor (EGF) receptor subfamily members typically exhibit robust kinase activity.

Purpose of the Study:

  • To investigate the protein tyrosine kinase activity of p180erbB3.
  • To compare the kinase activity of p180erbB3 with the human EGF receptor.
  • To determine if altered residues in p180erbB3 impair its catalytic function.

Main Methods:

  • Expression of human EGF receptor and bovine p180erbB3 in insect cells using baculovirus infection.
  • Comparison of autophosphorylation and substrate phosphorylation activities between EGF receptor and p180erbB3.

Related Experiment Videos

  • Assessment of ATP analog binding to p180erbB3 to confirm receptor integrity.
  • Main Results:

    • p180erbB3 exhibited autophosphorylation and substrate phosphorylation at least 2 orders of magnitude less efficiently than the EGF receptor.
    • EGF receptor showed robust EGF-stimulated autophosphorylation and substrate phosphorylation.
    • p180erbB3 successfully bound the ATP analog 5'-p-fluorosulfonylbenzoyladenosine, indicating functional receptor expression.

    Conclusions:

    • p180erbB3 possesses significantly impaired intrinsic tyrosine kinase activity.
    • The observed lack of kinase activity is likely due to alterations in catalytic residues, not receptor denaturation or non-functionality.
    • These findings suggest a specific functional deficiency in p180erbB3's kinase domain.